e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Lung cancer management and prognosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer
O. N. Shifrina, A. V. Bazhin, M. S. Savchenko, P. P. Philippov, A. G. Chuchalin (Moscow, Russia)
Source:
Annual Congress 2003 - Lung cancer management and prognosis
Session:
Lung cancer management and prognosis
Session type:
Oral Presentation
Number:
2550
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. N. Shifrina, A. V. Bazhin, M. S. Savchenko, P. P. Philippov, A. G. Chuchalin (Moscow, Russia). Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer. Eur Respir J 2003; 22: Suppl. 45, 2550
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
KI67: Analysis of its expression and prognostic significance in a resected non small cell lung cancer population
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters
Source: Eur Respir J 2007; 30: Suppl. 51, 670s
Year: 2007
Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool
Source: Annual Congress 2012 - New insights in the pathology of lung cancer
Year: 2012
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
Source: Eur Respir J 2011; 38: 657-663
Year: 2011
Characteristics and prognostic relevance of
p
53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005
Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
The clinical significance of soluble E-cadherin in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 769s
Year: 2006
Clinical correlates and prognostic significance of neuron specific enolase (NSE) in non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 73s
Year: 2002
Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Analysis of surgical stage lung cancer and tumour markers prognostic value
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006
Identification of genes with diagnostic and prognostic value in lung cancer.
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Telomerase activity as a prognostic marker in non small cell lung cancer
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008
The prognostic significance of circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide and neuron- specific enolase in patients with advanced non-small-cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Clinical significance and functional roles of FoxM1 in non-small cell lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer
Source: Eur Respir J 2001; 17: 660-666
Year: 2001
Detection of antibodies against recoverin in the serum of patients with small cell lung cancer in the absence of cancer-associated retinopathy
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001
Prognostic significance of MUC1 expression in resected lung adenocarcinoma
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Prognostic significance of Nestin in resected non-small cell lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
HER2/
Neu
overexpression as independent negative prognostic factor for non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept